Nasdaq 100 Stocks SEC Filings — February 12, 2026

13-02-2026

Immunic, Inc. filed a Form 8-K on 2026-02-13 disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, personnel names, share counts, or financial metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks quantitative data for impact assessment.

13-02-2026

13-02-2026

Atmus Filtration Technologies Inc. filed an 8-K on 2026-02-13 under Item 2.02 disclosing Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, positive or negative performance indicators, or other quantitative details are mentioned in the filing. Sector is not specified.

• ·AccNo: 0001921963-26-000012
• ·File Size: 492 KB

13-02-2026

Evommune, Inc. filed a Form 8-K on February 13, 2026, disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), alongside Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). While the material agreement signals potential strategic advancement, the equity sales raise dilution concerns. No specific transaction values, terms, financial impacts, or quantitative details are disclosed.

13-02-2026

GENCO SHIPPING & TRADING LTD filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, names, reasons, or timing were disclosed.

13-02-2026

13-02-2026

Inmune Bio, Inc. filed a Form 8-K on February 13, 2026 (AccNo: 0001213900-26-016385, Size: 291 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, or quantitative data are disclosed in the filing summary. This appears to be a multi-item voluntary disclosure likely including a press release or update as an exhibit.

13-02-2026

MID AMERICA APARTMENT COMMUNITIES INC. filed an 8-K on February 13, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the filing summary. This appears to be an informational disclosure without quantified financial metrics or directional impacts provided.

13-02-2026

Apple Hospitality REIT, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or timing are provided in the filing summary. No quantitative data, performance metrics, or further governance implications are disclosed.

13-02-2026

SAGA COMMUNICATIONS INC filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's name, title, reason for change, timing, or any quantitative metrics are disclosed.

13-02-2026

Faraday Future Intelligent Electric Inc. filed an 8-K on February 13, 2026, under Item 5.07 disclosing submission of matters to a vote of security holders, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. No specific vote outcomes, details of other events, financial metrics, or exhibit contents are disclosed. This multi-item filing provides informational updates without quantified positive or negative impacts.

13-02-2026

CoStar Group, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or terms are disclosed.

13-02-2026

NexMetals Mining Corp. filed an 8-K on 2026-02-13 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Other Events in Item 8.01 and Financial Statements and Exhibits in Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

Aditxt, Inc. filed an 8-K on February 13, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No specific matters submitted, vote outcomes, share counts, or other numerical details are disclosed. This is an informational filing on shareholder voting activity.